Domov › Parkinsonova bolezen › Michigan
Klinične študije za Parkinsonova bolezen v Michigan
21 študij za Parkinsonova bolezen išče udeležence na lokacijah v Michigan.
Mesta v Michigan
Uradno besedilo študije (angleško)
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- Quest Research Institute, Farmington Hills
Vključevanje udeležencevFaza 2
Starost 40–80 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06680830A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
- Quest Research Institute - Alcanza, Farmington Hills
Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci
Starost 30–80 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06565195A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Site-015, Farmington Hills
Vključevanje udeležencevFaza 2/3
Starost 40–80 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT06976268A Study of Buntanetap in Participants With PD
- Quest Research Institute, Farmington Hills
Vključevanje udeležencevFaza 2/3
Starost 40–85 · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT07284784Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
- University of Michigan, Ann Arbor
- Michigan State University, East Lansing
- Quest Research Institute, Farmington Hills
Vključevanje udeležencevFaza 2
Starost 40–80 · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT07005180A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #002, Farmington Hills
Vključevanje udeležencevFaza 2
Starost 18–65 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07804615A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- University of Michigan Health System (UMHS) (Site #202), Ann Arbor
- Quest Research Institute - Alcanza - PPDS (Site #201), Farmington Hills
Vključevanje udeležencevFaza 2
Starost 30–80 · Vsi spoli · Posodobljeno 10. sep. 2026 · NCT07432958A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations
- Quest Research Institute - Alcanza - HyperCore - PPDS, Farmington Hills
Vključevanje udeležencevFaza 2
Starost 40–85 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT07514858A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
- University of Michigan, Ann Arbor
Vključevanje udeležencevOpazovalna študija
Starost 45–75 · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT07330258A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Quest Research Institute, Farmington Hills
Vključevanje udeležencevFaza 3
Starost 50–85 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07174310A Pilot Study of In-lab Dynamic Standing in Parkinson's Disease
- Domino's Farms, Ann Arbor
Vključevanje udeležencevFaza 1
Starost 50 in več · Vsi spoli · Posodobljeno 14. avg. 2026 · NCT07543861A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- Michigan Clinical Research Unit - Neurology, Ann Arbor
- University of Michigan Clinical Research Unit - Neurology, Ann Arbor
- Quest Research Institute, Farmington Hills
Vključevanje udeležencevFaza 3
Starost 45–75 · Vsi spoli · Posodobljeno 4. avg. 2026 · NCT06944522PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- University of Michigan, Ann Arbor
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 30 in več · Vsi spoli · Posodobljeno 27. jul. 2026 · NCT04477785Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation
- University of Michigan, Ann Arbor
Vključevanje udeležencevOpazovalna študija
Starost 45 in več · Vsi spoli · Posodobljeno 11. jun. 2026 · NCT07642908Natural History Study of Synucleinopathies
- University of Michigan, Ann Arbor
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 10. jun. 2026 · NCT01799915SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
- Quest Research Institute, Farmington Hills
Vključevanje udeležencevFaza 1
Starost 40–80 · Vsi spoli · Posodobljeno 5. jun. 2026 · NCT07422675Speech Amplification Devices for Parkinson Disease: Talker- and Technology-Driven Enhancements
- Michigan State University, East Lansing
Vključevanje udeležencev
Starost 50 in več · Vsi spoli · Posodobljeno 20. maj 2026 · NCT07599696A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
- QUEST Research Institute, Farmington Hills
Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci
Starost 30–85 · Vsi spoli · Posodobljeno 20. apr. 2026 · NCT06809400Reducing Falls With Varenicline in Hypocholinergic Parkinson Disease
- University of Michigan, Ann Arbor
Vključevanje udeležencevFaza 2
Starost 45 in več · Vsi spoli · Posodobljeno 31. mar. 2026 · NCT06679374Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments
- Domino's Farms, Ann Arbor
Vključevanje udeležencevFaza 1/2
Starost 45 in več · Vsi spoli · Posodobljeno 12. nov. 2025 · NCT07154511A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
- Quest Research Institute, Farmington Hills
Vključevanje udeležencevFaza 4
Starost 18 in več · Vsi spoli · Posodobljeno 24. avg. 2025 · NCT06765668Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.